Josef Gillson

PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression.

J. Samra, A. Gill, M. Molloy, 2020, Biochimica et biophysica acta. General subjects.

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target

N. Pavlakis, J. Samra, S. Sahni, 2022, Cancers.

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?

N. Pavlakis, J. Samra, A. Gorfe, 2020, Cancers.

Autophagy: A Promising Target for Triple Negative Breast Cancers.

S. Sahni, P. Jansson, Yomna S. Abd El-Aziz, 2021, Pharmacological research.

NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.

D. Richardson, K. Park, S. Sahni, 2020, Biochimica et biophysica acta. General subjects.

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

J. Samra, A. Gill, S. Sahni, 2023, Cancer medicine.